For research use only. Not for therapeutic Use.
3-Indolepropionic Acid-d2 (CAS: 2469257-98-3), a high-quality pharmaceutical research compound designed for advanced studies in neuroprotection and antioxidant research. As a deuterated analog of 3-Indolepropionic acid, it offers enhanced stability and improved pharmacokinetic properties. 3-Indolepropionic Acid-d2 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for neurodegenerative diseases and oxidative stress. Trusted by leading laboratories, 3-Indolepropionic Acid-d2 is your go-to solution for cutting-edge neuroprotection research. Unlock new possibilities in brain health and antioxidant therapies with 3-Indolepropionic Acid-d2, where innovation meets reliability.
| Catalog Number | S000162 |
| CAS Number | 2469257-98-3 |
| Molecular Formula | C11H9D2NO2 |
| Purity | ≥95% |
| IUPAC Name | 2,2-dideuterio-3-(1H-indol-3-yl)propanoic acid |
| InChI | InChI=1S/C11H11NO2/c13-11(14)6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6H2,(H,13,14)/i6D2 |
| InChIKey | GOLXRNDWAUTYKT-NCYHJHSESA-N |
| SMILES | [2H]C([2H])(CC1=CNC2=CC=CC=C21)C(=O)O |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Wikoff WR, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3698-703. [3]. Reiter RJ, et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci. 1998 Nov 20;854:410-24. [4]. de Mello VDet al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci Rep. 2017 Apr 11;7:46337. doi: 10.1038/srep46337. |
